Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insulins

M R Burge1, D S Schade

  • 1Department of Medicine, University of New Mexico School of Medicine, Albuquerque, USA.

Endocrinology and Metabolism Clinics of North America
|October 6, 1997
PubMed
Summary
This summary is machine-generated.

Achieving near-normal blood glucose control in diabetes therapy is possible with current pharmacologic tools. Optimal diabetes management requires understanding insulin pharmacology and employing creative, patient-specific strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metabolic Effects of Androgen-associated Body Mass in Klinefelter Syndrome.

Archives of medicine·2019
Same author

Predictors of Physical Fitness among Southwestern Native American Adolescents at Risk for Diabetes.

Journal of pediatric endocrinology (Jersey City, N.J.)·2017
Same author

Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.

Molecular psychiatry·2017
Same author

Lispro insulin: benefits and limitations.

Trends in endocrinology and metabolism: TEM·2008
Same author

Ten pivotal questions about diabetic ketoacidosis. Answers that clarify new concepts in treatment.

Postgraduate medicine·2001
Same author

Effect of short-term glucose control on glycemic thresholds for epinephrine and hypoglycemic symptoms.

The Journal of clinical endocrinology and metabolism·2001
Same journal

Navigating Adrenal Disease: A Comprehensive, Practical Guide for the Clinician.

Endocrinology and metabolism clinics of North America·2026
Same journal

Adrenal Disorders in Pregnancy.

Endocrinology and metabolism clinics of North America·2026
Same journal

Diagnosis and Management of Adrenocortical Carcinoma.

Endocrinology and metabolism clinics of North America·2026
Same journal

Pheochromocytomas and Paragangliomas.

Endocrinology and metabolism clinics of North America·2026
Same journal

Hereditary Conditions Associated with Adrenocortical Carcinoma, Pheochromocytoma, and Other Adrenal Tumors: Genetic Testing and Management Recommendations.

Endocrinology and metabolism clinics of North America·2026
Same journal

Primary Bilateral Macronodular Adrenal Hyperplasia.

Endocrinology and metabolism clinics of North America·2026
See all related articles

Area of Science:

  • Endocrinology
  • Pharmacology
  • Metabolic Diseases

Background:

  • Current diabetes therapy offers advanced pharmacologic tools for near-normal blood glucose control.
  • Effective management hinges on a thorough understanding of insulin pharmacology and limitations.

Purpose of the Study:

  • To highlight the importance of comprehensive knowledge of insulin pharmacology for optimal diabetes management.
  • To emphasize the role of individualized, creative strategies in achieving therapeutic goals.

Main Methods:

  • Review of current pharmacologic tools in diabetes therapy.
  • Analysis of the pharmacology and limitations of available insulins.
  • Discussion of innovative approaches and future therapeutic developments.

Related Experiment Videos

Main Results:

  • Near-normal blood glucose control is attainable with existing insulin therapies.
  • Knowledge of insulin properties and patient-specific approaches are crucial for success.
  • Ongoing advancements in insulin analogues and delivery systems promise expanded therapeutic options.

Conclusions:

  • Optimal diabetes management requires a deep understanding of insulin pharmacology and a flexible, patient-centered approach.
  • Future developments in insulin therapy are expected to further enhance patient quality of life and health outcomes.